Systopic has a long standing association with the Gastroenterology segment. We specialize in offering therapeutic solutions for the management of Irritable Bowel Syndrome, Acid-peptic disorders & Hepatoprotection. Normaxin is our flagship brand in IBS segment wherein we pioneered by providing a triple combination of an antispasmodic, antisecretory & an anxiolytic for comprehensive IBS management. We galvanized the APD market with the launch of Cyra which offers the cyber age proton pump inhibitor rabeprazole. With its unique release pattern, Cyra-D, is the most preferred option in co-existing reflux & dyspepsia. Hepatoprotectives is another key segment for us wherein we market a naturally acting liver activator in the form of Analiv in both oral & injectable forms.